{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:09:47Z","timestamp":1758816587030},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T00:00:00Z","timestamp":1377648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00259-013-2541-5","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T07:21:48Z","timestamp":1377588108000},"page":"253-259","source":"Crossref","is-referenced-by-count":8,"title":["131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study"],"prefix":"10.1007","volume":"41","author":[{"name":"Health Data Analysis in Taiwan (hDATa) Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Mu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tse","family":"Tsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hsing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,28]]},"reference":[{"issue":"9684","key":"2541_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145\u201358. doi: 10.1016\/S0140-6736(09)60507-9 .","journal-title":"Lancet"},{"issue":"2","key":"2541_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-010-9315-7","volume":"37","author":"HH Chen","year":"2010","unstructured":"Chen HH, Chen YW, Wu CJ. Primary hyperparathyroidism in Taiwan: clinical features and prevalence in a single-center experience. Endocrine. 2010;37(2):373\u20138. doi: 10.1007\/s12020-010-9315-7 .","journal-title":"Endocrine"},{"issue":"3","key":"2541_CR3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Amy Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122\u20139. doi: 10.1210\/jc.2012-4022 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2541_CR4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1097-0142(19851001)56:7<1529::AID-CNCR2820560710>3.0.CO;2-D","volume":"56","author":"LE Tisell","year":"1985","unstructured":"Tisell LE, Carlsson S, Fjalling M, Hansson G, Lindberg S, Lundberg LM, et al. Hyperparathyroidism subsequent to neck irradiation. Risk factors. Cancer. 1985;56(7):1529\u201333.","journal-title":"Cancer"},{"issue":"1","key":"2541_CR5","first-page":"254","volume":"80","author":"AB Schneider","year":"1995","unstructured":"Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin J. Dose\u2013response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab. 1995;80(1):254\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2541_CR6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1667\/0033-7587(2002)158[0418:DRRFPA]2.0.CO;2","volume":"158","author":"E Holmberg","year":"2002","unstructured":"Holmberg E, Wallgren A, Holm LE, Lundell M, Karlsson P. Dose\u2013response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy. Radiat Res. 2002;158(4):418\u201323.","journal-title":"Radiat Res"},{"issue":"5","key":"2541_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1990.03450050039024","volume":"264","author":"J Cohen","year":"1990","unstructured":"Cohen J, Gierlowski TC, Schneider AB. A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA. 1990;264(5):581\u20134.","journal-title":"JAMA"},{"issue":"3","key":"2541_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2307\/3578384","volume":"130","author":"S Fujiwara","year":"1992","unstructured":"Fujiwara S, Sposto R, Ezaki H, Akiba S, Neriishi K, Kodama K, et al. Hyperparathyroidism among atomic bomb survivors in Hiroshima. Radiat Res. 1992;130(3):372\u20138.","journal-title":"Radiat Res"},{"issue":"7","key":"2541_CR9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMc1104982","volume":"365","author":"BO Boehm","year":"2011","unstructured":"Boehm BO, Rosinger S, Belyi D, Dietrich JW. The parathyroid as a target for radiation damage. N Engl J Med. 2011;365(7):676\u20138. doi: 10.1056\/NEJMc1104982 .","journal-title":"N Engl J Med"},{"issue":"6","key":"2541_CR10","first-page":"1025","volume":"106","author":"AG Bondeson","year":"1989","unstructured":"Bondeson AG, Bondeson L, Thompson NW. Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence? Surgery. 1989;106(6):1025\u20137.","journal-title":"Surgery"},{"issue":"8","key":"2541_CR11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/02841860500516618","volume":"45","author":"T Rasmuson","year":"2006","unstructured":"Rasmuson T, Tavelin B. Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine. Acta Oncol. 2006;45(8):1059\u201361. doi: 10.1080\/02841860500516618 .","journal-title":"Acta Oncol"},{"issue":"12","key":"2541_CR12","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","volume":"31","author":"YT Tsan","year":"2013","unstructured":"Tsan YT, Lee CH, Ho WC, Lin MH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol. 2013;31(12):1514\u201321. doi: 10.1200\/JCO.2012.44.6831 .","journal-title":"J Clin Oncol"},{"issue":"9","key":"2541_CR13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","volume":"12","author":"HW Lin","year":"2011","unstructured":"Lin HW, Tu YY, Lin SY, Su WJ, Lin WL, Lin WZ, et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol. 2011;12(9):900\u20134. doi: 10.1016\/S1470-2045(11)70165-6 .","journal-title":"Lancet Oncol"},{"issue":"22","key":"2541_CR14","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2011.35.1908","volume":"29","author":"CH Chang","year":"2011","unstructured":"Chang CH, Lin JW, Wu LC, Lai MS. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study. J Clin Oncol. 2011;29(22):3001\u20137. doi: 10.1200\/JCO.2011.35.1908 .","journal-title":"J Clin Oncol"},{"issue":"18","key":"2541_CR15","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1200\/JCO.2009.26.0695","volume":"28","author":"CY Wu","year":"2010","unstructured":"Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol. 2010;28(18):2952\u20137. doi: 10.1200\/JCO.2009.26.0695 .","journal-title":"J Clin Oncol"},{"issue":"3","key":"2541_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","volume":"102","author":"MN Lai","year":"2010","unstructured":"Lai MN, Wang SM, Chen PC, Chen YY, Wang JD. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst. 2010;102(3):179\u201386. doi: 10.1093\/jnci\/djp467 .","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"2541_CR17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167\u2013214. doi: 10.1089\/thy.2009.0110 .","journal-title":"Thyroid"},{"issue":"3","key":"2541_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.amjsurg.2007.04.005","volume":"194","author":"SM Colaco","year":"2007","unstructured":"Colaco SM, Si M, Reiff E, Clark OH. Hyperparathyroidism after radioactive iodine therapy. Am J Surg. 2007;194(3):323\u20137. doi: 10.1016\/j.amjsurg.2007.04.005 .","journal-title":"Am J Surg"},{"issue":"12","key":"2541_CR19","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"SA Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985\u20131995. Cancer. 1998;83(12):2638\u201348. doi: 10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2\u20131 .","journal-title":"Cancer"},{"key":"2541_CR20","unstructured":"Cancer registry annual report (2008) Bureau of Health Promotion, Department of Health, Taiwan."},{"issue":"11","key":"2541_CR21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1089\/thy.2012.0302","volume":"22","author":"RC Smallridge","year":"2012","unstructured":"Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22(11):1104\u201339. doi: 10.1089\/thy.2012.0302 .","journal-title":"Thyroid"},{"issue":"6","key":"2541_CR22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","volume":"19","author":"RT Kloos","year":"2009","unstructured":"Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565\u2013612. doi: 10.1089\/thy.2008.0403 .","journal-title":"Thyroid"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2541-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2541-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2541-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:05:31Z","timestamp":1558713931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2541-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,28]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2541"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2541-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"type":"print","value":"1619-7070"},{"type":"electronic","value":"1619-7089"}],"subject":[],"published":{"date-parts":[[2013,8,28]]}}}